Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Maintain Quality While Improving Productivity

Wednesday, February 15, 2017

In todays fastpaced world chemical companies are always striving to remain one step ahead and deliver highquality products on time and within budget As a result there is everincreasing pressure toimprove processefficiencyTo help manufacturers imp...

MicroPort commences local commercial operations in India

Tuesday, February 28, 2017

MicroPort Scientific Corporation MPSC HK a leading global medical technology company dedicated to the innovation manufacturing and marketing of highend medical devices today announced the commencement of its Indian operations The Indian arm MicroPor...

Titan Pharmaceuticals Receives FDA Communication On Ropinirole Implant Investigational New Drug Application

Tuesday, February 28, 2017

Titan Pharmaceuticals Inc a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura longterm continuous drug delivery platform today announced that the US Food Drug Administration FDA has compl...

Sunovion Announces Positive Topline Results from Study Evaluating Latuda® (lurasidone HCl) in Children and Adolescents with Bipolar Depression

Tuesday, February 28, 2017

Sunovion Pharmaceuticals Inc today announced that its Phase clinical study evaluating Latuda lurasidone HCl in children and adolescents aged to years with depression associated with bipolar I disorder bipolar depression met its primary endpoint LA...

Merck’s Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) Infection in Bone Marrow Transplant Recipients, Highly Effective Through Week 24 Post-Transpl

Monday, February 27, 2017

Merck Co Inc known as MSD outside the United States and Canada today announced results of the pivotal Phase clinical study of letermovir an investigational antiviral medicine for the prevention of clinicallysignificant cytomegalovirus CMV infection...

Antibe Therapeutics Enters into Regional Licensing Deal

Saturday, February 25, 2017

Antibe Therapeutics Inc is pleased to announce today that it has signed an exclusive licensing and distribution agreement with Laboratories Acbel SA Acbel for ATB in Greece Romania Serbia Bulgaria Albania Algeria and Jordan Acbel is a pharmaceutical...

Acticor Biotech Has Selected Its Contract Research Organisation to Manage Clinical Study Phase I

Friday, February 24, 2017

Acticor Biotech a biotechnology company focused on the treatment of acute ischemic stroke today announced that it selected its CRO Contract Research Organization to manage its clinical study phase IThe firstinhuman study with ACT will be conducte...

Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments

Friday, February 24, 2017

Fusion Pharmaceuticals a newly formed biopharmaceutical company developing targeted alphaparticle radiotherapeutics for treating cancer today announced the closing of a million Series A financing led by founding venture investor Johnson Johnson Inn...

Lannett Provides Further Update On Methylphenidate ER Tablets

Thursday, February 23, 2017

Lannett Company Inc announced that it was notified by US Food and Drug Administration FDA late yesterday afternoon that FDA suspended indefinitely the deadline for the Company to submit materials in support of its request for a hearing to consider FD...

PMV Pharma Secures $74 Million in Series B Financing for Cancer Drugs Targeting p53

Thursday, February 23, 2017

PMV Pharmaceuticals Inc a leader in the discovery and development of ptargeted small molecule drugs for the treatment of cancer today announced the completion of a million Series B financing round This financing was led by Topspin Biotech Fund and a...